Fate Therapeutics

Clinical-stage biopharmaceutical company pioneering the development of off-the-shelf, iPSC-derived cellular immunotherapies for cancer and immune disorders.

Location
San Diego, California, USA
Founded
2007
Investors
1
Categories
biotech, cell-therapy, ipsc, immunotherapy, oncology, public-company

Investors

NameLocationTypeStagesPortfolio
Polaris PartnersUSbiotech-focused-33